Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$40.26 - $57.37 $157,980 - $225,119
-3,924 Closed
0 $0
Q2 2021

Jul 29, 2021

BUY
$54.88 - $79.29 $19,647 - $28,385
358 Added 10.04%
3,924 $223,000
Q1 2021

Apr 12, 2021

BUY
$70.65 - $96.76 $21,195 - $29,028
300 Added 9.19%
3,566 $273,000
Q4 2020

Feb 10, 2021

BUY
$58.41 - $89.06 $190,767 - $290,869
3,266 New
3,266 $271,000

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $326M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track High Point Advisor Group LLC Portfolio

Follow High Point Advisor Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.